Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Published in: Obesity Surgery 10/2015

01-10-2015 | Letter to the Editor

Improvement of Kidney Function Following Bariatric Surgery: Hope or Illusion?

Authors: G. Favre, A. S. Schneck, R. Anty, V. L. M. Esnault, A. Iannelli

Published in: Obesity Surgery | Issue 10/2015

Login to get access

Excerpt

Many studies have established obesity as an independent risk factor for kidney diseases. The question whether bariatric surgery could slow the progression of chronic kidney disease (CKD) is of paramount importance given the parallel increase in the prevalence of obesity and CKD. The latter is characterized by a glomerular filtration rate (GFR) <60 ml/min/1.73 m2 and by a low reserve in filtration capacity. Obesity is a reversible cause of stimulation of the reserve of filtration capacity called glomerular hyperfiltration, which is harmful to kidney function in the long term. Furthermore, obesity is associated with the reversible production of adipocytokines, which may directly damage the kidneys. Therefore, a beneficial effect of bariatric surgery on kidney function can be anticipated. However, the appreciation of GFR in extreme obese patients is difficult and available studies on this topic should be cautiously interpreted. In the present letter, we would like to briefly review the evidence for the hope and doubts regarding the benefit of bariatric surgery in CKD patients. …
Literature
1.
Hsu CY, McCulloch CE, Iribarren C, et al. Body mass index and risk for end-stage renal disease. Ann Intern Med. 2006;144(1):21–8.CrossRefPubMed
2.
Kambham N, Markowitz GS, Valeri AM, et al. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int. 2001;59(4):1498–509.CrossRefPubMed
3.
Bonnet F, Deprele C, Sassolas A, et al. Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis. Am J Kidney Dis. 2001;37(4):720–7.CrossRefPubMed
4.
Praga M, Hernandez E, Herrero JC, et al. Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy. Kidney Int. 2000;58(5):2111–8.CrossRefPubMed
5.
Bosma RJ, Kwakernaak AJ, van der Heide JJ, et al. Body mass index and glomerular hyperfiltration in renal transplant recipients: cross-sectional analysis and long-term impact. Am J Transplant. 2007;7(3):645–52.CrossRefPubMed
6.
7.
Guo G, Morrissey J, McCracken R, et al. Contributions of angiotensin II and tumor necrosis factor-alpha to the development of renal fibrosis. Am J Physiol Ren Physiol. 2001;280(5):F777–85.
8.
9.
Ohashi K, Iwatani H, Kihara S, et al. Exacerbation of albuminuria and renal fibrosis in subtotal renal ablation model of adiponectin-knockout mice. Arterioscler Thromb Vasc Biol. 2007;27(9):1910–7.CrossRefPubMed
10.
Ahmed SB, Fisher ND, Stevanovic R, et al. Body mass index and angiotensin-dependent control of the renal circulation in healthy humans. Hypertension. 2005;46(6):1316–20.CrossRefPubMed
11.
Solerte SB, Rondanelli M, Giacchero R, et al. Serum glucagon concentration and hyperinsulinaemia influence renal haemodynamics and urinary protein loss in normotensive patients with central obesity. Int J Obes Relat Metab Disord. 1999;23(9):997–1003.CrossRefPubMed
12.
Helal I, Fick-Brosnahan GM, Reed-Gitomer B, et al. Glomerular hyperfiltration: definitions, mechanisms and clinical implications. Nat Rev Nephrol. 2012;8(5):293–300.CrossRefPubMed
13.
Kwakernaak AJ, Zelle DM, Bakker SJ, et al. Central body fat distribution associates with unfavorable renal hemodynamics independent of body mass index. J Am Soc Nephrol. 2013;24:987–94.PubMedCentralCrossRefPubMed
14.
Pinto-Sietsma SJ, Navis G, Janssen WM, et al. A central body fat distribution is related to renal function impairment, even in lean subjects. Am J Kidney Dis. 2003;41(4):733–41.CrossRefPubMed
15.
Kurella M, Lo JC, Chertow GM. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol. 2005;16(7):2134–40.CrossRefPubMed
16.
Shoja MM, Tubbs RS, Loukas M, et al. The sub-peritoneal arterial plexus of Sir William Turner. Ann Anat. 2010;192(4):194–8.CrossRefPubMed
17.
Foster MC, Hwang SJ, Porter SA, et al. Fatty kidney, hypertension, and chronic kidney disease: the framingham heart study. Hypertension. 2011;58(5):784–90.PubMedCentralCrossRefPubMed
18.
Wagner R, Machann J, Lehmann R, et al. Exercise-induced albuminuria is associated with perivascular renal sinus fat in individuals at increased risk of type 2 diabetes. Diabetologia. 2012;55(7):2054–8.CrossRefPubMed
19.
Chagnac A, Weinstein T, Herman M, et al. The effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol. 2003;14(6):1480–6.CrossRefPubMed
20.
Brochner-Mortensen J, Rickers H, Balslev I. Renal function and body composition before and after intestinal bypass operation in obese patients. Scand J Clin Lab Invest. 1980;40(8):695–702.CrossRefPubMed
21.
Hou CC, Shyu RS, Lee WJ, et al. Improved renal function 12 months after bariatric surgery. Surg Obes Relat Dis. 2013;9(2):202–6.CrossRefPubMed
22.
Navaneethan SD, Yehnert H. Bariatric surgery and progression of chronic kidney disease. Surg Obes Relat Dis. 2009;5(6):662–5.CrossRefPubMed
23.
Iannelli A, Martini F, Rodolphe A, et al. Body composition, anthropometrics, energy expenditure, systemic inflammation, in premenopausal women 1 year after laparoscopic Roux-en-Y gastric bypass. Surg Endosc. 2014;28(2):500–7.CrossRefPubMed
24.
Stevens LA, Coresh J, Schmid CH, et al. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis. 2008;51(3):395–406.PubMedCentralCrossRefPubMed
Metadata
Title
Improvement of Kidney Function Following Bariatric Surgery: Hope or Illusion?
Authors
G. Favre
A. S. Schneck
R. Anty
V. L. M. Esnault
A. Iannelli
Publication date
01-10-2015
Publisher
Springer US
Published in
Obesity Surgery / Issue 10/2015
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-015-1819-z

Other articles of this Issue 10/2015

Obesity Surgery 10/2015 Go to the issue

Original Contributions

Cardiovascular Changes After Gastric Bypass Surgery: Involvement of Increased Secretions of Glucagon-Like Peptide-1 and Brain Natriuretic Peptide

Original Contributions

abiliti® Closed-Loop Gastric Electrical Stimulation System for Treatment of Obesity: Clinical Results with a 27-Month Follow-Up

Video Submission

Trans-Umbilical Single Incision Laparoscopic Sleeve Gastrectomy in a Patient with Situs Inversus Totalis and Kartagener Syndrome: Video Report

Original Contributions

Use of Enoxaparin in Obese Adolescents During Bariatric Surgery—a Pilot Study

Original Contributions

Expedited Biliopancreatic Juice Flow to the Distal Gut Benefits the Diabetes Control After Duodenal-Jejunal Bypass

Video Submission

Endoscopic Management of Massive Hemorrhage 12 h Post Laparoscopic Roux-en-Y Gastric Bypass